News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
97,778 Results
Type
Article (7123)
Company Profile (40)
Press Release (90611)
Multimedia
Podcasts (17)
Webinars (2)
Section
Business (27821)
Career Advice (128)
Deals (4003)
Drug Delivery (40)
Drug Development (14225)
Employer Resources (12)
FDA (3001)
Job Trends (2128)
News (49586)
Policy (6092)
Tag
2027 Pharm Country Standard (2)
Academia (433)
Accelerated approval (15)
Adcomms (7)
Allergies (46)
Alliances (9044)
ALS (34)
Alzheimer's disease (341)
Antibody-drug conjugate (ADC) (115)
Approvals (2976)
Artificial intelligence (125)
Autoimmune disease (51)
Automation (9)
Bankruptcy (19)
Best Places to Work (1795)
BIOSECURE Act (17)
Biosimilars (141)
Biotechnology (29)
Bladder cancer (42)
Brain cancer (14)
Breast cancer (129)
Cancer (1005)
Cardiovascular disease (51)
Career advice (116)
Career pathing (5)
CAR-T (49)
CDC (9)
Cell therapy (170)
Cervical cancer (8)
Clinical research (12386)
Collaboration (453)
Compensation (98)
Complete response letters (24)
COVID-19 (594)
CRISPR (12)
C-suite (163)
Cystic fibrosis (17)
Data (1396)
Denatured (6)
Depression (15)
Diabetes (71)
Diagnostics (606)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (88)
Drug pricing (42)
Drug shortages (1)
Duchenne muscular dystrophy (76)
Earnings (10170)
Editorial (16)
Employer branding (3)
Employer resources (10)
Events (12690)
Executive appointments (169)
FDA (3805)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (290)
Gene editing (45)
Generative AI (18)
Gene therapy (182)
GLP-1 (150)
Government (1397)
Grass and pollen (1)
Guidances (81)
Healthcare (1954)
HIV (11)
Huntington's disease (14)
IgA nephropathy (20)
Immunology and inflammation (95)
Immuno-oncology (24)
Indications (23)
Infectious disease (661)
Inflammatory bowel disease (67)
Inflation Reduction Act (7)
Influenza (32)
Intellectual property (37)
Interviews (11)
IPO (1848)
IRA (16)
Job creations (388)
Job search strategy (108)
JPM (9)
Kidney cancer (3)
Labor market (8)
Layoffs (68)
Leadership (3)
Legal (564)
Liver cancer (13)
Longevity (9)
Lung cancer (154)
Lymphoma (71)
Machine learning (14)
Management (2)
Manufacturing (302)
MASH (30)
Medical device (1196)
Medtech (1208)
Mergers & acquisitions (2348)
Metabolic disorders (183)
Multiple sclerosis (41)
NASH (2)
Neurodegenerative disease (69)
Neuropsychiatric disorders (8)
Neuroscience (567)
NextGen: Class of 2026 (696)
Non-profit (358)
Now hiring (15)
Obesity (70)
Opinion (65)
Ovarian cancer (40)
Pain (23)
Pancreatic cancer (32)
Parkinson's disease (44)
Partnered (10)
Patents (71)
Patient recruitment (82)
Peanut (25)
People (8310)
Pharmaceutical (9)
Pharmacy benefit managers (7)
Phase 1 (4074)
Phase 2 (5138)
Phase 3 (4537)
Pipeline (1299)
Policy (120)
Postmarket research (298)
Preclinical (1600)
Press Release (66)
Prostate cancer (39)
Psychedelics (6)
Radiopharmaceuticals (41)
Rare diseases (197)
Real estate (931)
Recruiting (4)
Regulatory (5434)
Reports (11)
Research institute (397)
Resumes & cover letters (11)
Rett syndrome (5)
RNA editing (3)
RSV (17)
Schizophrenia (28)
Series A (51)
Series B (28)
Service/supplier (3)
Sickle cell disease (20)
Special edition (5)
Spinal muscular atrophy (23)
Sponsored (14)
Startups (592)
State (1)
Stomach cancer (5)
Supply chain (16)
Tariffs (21)
The Weekly (11)
Vaccines (292)
Venture capital (15)
Weight loss (29)
Women's health (7)
Date
Today (1)
Last 7 days (114)
Last 30 days (519)
Last 365 days (6038)
2026 (649)
2025 (6023)
2024 (6508)
2023 (6962)
2022 (9056)
2021 (9473)
2020 (8172)
2019 (5837)
2018 (4510)
2017 (5058)
2016 (4617)
2015 (5269)
2014 (3717)
2013 (2892)
2012 (2985)
2011 (3146)
2010 (2572)
Location
Africa (99)
Alabama (18)
Alaska (1)
Arizona (18)
Arkansas (2)
Asia (7989)
Australia (916)
California (2195)
Canada (430)
China (380)
Colorado (48)
Connecticut (58)
Delaware (99)
Europe (14594)
Florida (302)
Georgia (38)
Hawaii (1)
Idaho (14)
Illinois (95)
India (34)
Indiana (57)
Iowa (10)
Japan (97)
Kansas (7)
Kentucky (13)
Louisiana (2)
Maine (5)
Maryland (444)
Massachusetts (1605)
Michigan (32)
Minnesota (75)
Mississippi (4)
Missouri (23)
Montana (5)
Nebraska (1)
Nevada (12)
New Hampshire (5)
New Jersey (737)
New Mexico (4)
New York (562)
North Carolina (296)
North Dakota (9)
Northern California (1054)
Ohio (64)
Oklahoma (11)
Oregon (5)
Pennsylvania (316)
Puerto Rico (2)
Rhode Island (6)
South America (140)
South Carolina (3)
Southern California (916)
Tennessee (7)
Texas (325)
United States (7486)
Utah (43)
Virginia (27)
Washington D.C. (8)
Washington State (172)
West Virginia (1)
Wisconsin (15)
97,778 Results for "gensight biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GenSight Biologics Announces the Results of its Extraordinary General Meeting of January 28, 2026
January 29, 2026
·
2 min read
Press Releases
GenSight Biologics Reports Cash Position as of December 31, 2025, and Provides Business Updates
January 9, 2026
·
4 min read
Press Releases
GenSight Biologics Announces Regulatory Authorization for Early Access Treatment with GS010/LUMEVOQ® in Israel
December 23, 2025
·
5 min read
Press Releases
GenSight Biologics Announces the Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ® in France
December 22, 2025
·
2 min read
Press Releases
GenSight Biologics Announces Regulatory Approval for GS010/LUMEVOQ® REVISE Dose-Ranging Study in France
December 3, 2025
·
4 min read
Press Releases
GenSight Biologics Reports Cash Position as of September 30, 2025
October 7, 2025
·
3 min read
Press Releases
GenSight Biologics Reports Interim Financial Results for the First Half of 2025
September 29, 2025
·
11 min read
Press Releases
GenSight Biologics Announces Regulatory Authorizations for Individual Patient Expanded Access Treatment with GS010/LUMEVOQ® in the US
October 30, 2025
·
4 min read
Press Releases
GenSight Biologics Postpones Release of 2025 Half-Year Financial Results
August 29, 2025
·
2 min read
Press Releases
GenSight Biologics Reports Cash Position as of June 30, 2025
July 9, 2025
·
5 min read
1 of 9,778
Next
